24 apr: Debitormassens sammensætning for konverterbare obligationsserier,..
24 apr: Fortegningsemission i Conferize A/S gennemføres ikke. Ny ledelse ..
24-04-2019 09:46:06

NNIT acquires Swiss-based consultancy business

This press release expands upon Company Announcement 6/2019, published April 24, 2019, 09.35 a.m. CET.

NNIT acquires Swiss-based consultancy business

Access to leading experts within life sciences IT expands NNIT’s portfolio of services to the life sciences industry.

Copenhagen, April 24, 2019 –NNIT A/S announces that it has acquired Halfmann Goetsch Partner AG (HGP). The acquisition provides NNIT with a stronger presence in European life sciences hubs Frankfurt and Basel, and strengthens its position as an international leading IT transformation partner for life sciences companies.

HGP, recognized and referenced as one of the strongest providers of IT compliance and quality management services to primarily pharmaceutical companies, is headquartered in Basel close to NNIT’s Swiss office in Zürich. Furthermore, the company has delivery centers in Frankfurt and Singapore, and a nearshore office in Krakow.

HGP started out in Basel in 2008 as a business consultancy dedicated to IT compliance services to the pharmaceutical industry, and clients include companies such as Merck, Novartis and Hoffmann La-Roche.

With more than 10 years in business, the company employs 70 experts with extensive experience delivering highly specialized offerings such as Information Risk Management, Computer System Validation (CSV), Manufacturing Execution Systems (MES) Implementation, Data Privacy (GDPR), Data Integrity, Good Manufacturing Practices, Track & Trace and Audit Readiness.

Data collection intensifies within life sciences, and at the same time regulatory requirements increase with industry-specific regulation and general data privacy laws. As the technological opportunities and the pressure for legal compliance increase, the market for risk management and validation of data systems grows significantly. 

With a flexible consultancy base and access to top subject matter experts from across the international life sciences IT arena, Halfmann Goetsch Partner AG offers the industry leading approach to compliance excellence.

“Beyond the perfect geographical match in line with NNIT’s strategic plan to strengthen presence in the European life sciences hubs; Basel and Frankfurt, our employees complement each other very well,” explains Per Kogut, CEO, NNIT:

“Together we share a deep understanding of IT compliance and regulatory requirements for life sciences companies.”

Combined with NNIT’s existing quality management portfolio, HGP’s excellence, reputation and network within IT compliance is expected to generate cross sales synergies. Synergies are also expected within pharmaceutical production, where HGP’s thought leadership fits well with NNIT’s existing portfolio of IT-services.

“We are excited to become part of the NNIT Group and continue our successful development,” says Thomas Halfmann, founder and partner of Halfmann Goetsch Partner. He continues: “Benefitting from NNIT’s global delivery model we will continue to deliver high quality solutions using our capabilities and world class skills within life sciences IT. Our shared understanding of IT compliance and regulatory requirements constitutes a perfect match.”

Following the acquisition HGP will be integrated in NNIT, and management will continue in the leadership of the European life sciences business.

In May 2017, NNIT acquired SCALES Group. In October 2018, NNIT acquired Valiance Partners.

***

More information

Helga Heyn, NNIT Communications, +45 30 77 81 41, hhey@nnit.com

About Halfmann Goetsch Partner AG 

https://www.hgp.ag/

About NNIT

NNIT is an international consultancy in the development, implementation, validation and operation of IT for the life sciences industry. Globally, NNIT A/S has more than 3,200 employees. www.nnit.com

Attachment

logo.JPG

Relateret indhold
20 maj - 
Krisen kradser i NNIT: Aktien tæt på noteringskursen ef..
15 maj - 
Onsdagens aktier: Danske Bank presset af handelskrig og..
15 maj - 
Aktier/middag: Intet handelsnyt er skidt nyt for Danske..
Relateret debat
24 maj - 
Synes, det ser fornuftigt ud pt. Mon ikke den hurtigt k..
22 maj - 
jo jeg har tænkt det sammen den er virkelig faldet alt ..
20 maj - 
Er NNIT ikke ved at være prissat fornuftigt nu ? Overve..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
24 maj
NNIT
Synes, det ser fornuftigt ud pt. Mon ikke den hurtigt kan komme op i 160 - 170 . Lau Svendsen talte ..
1

Lars Christensens Verden - Episode 19: The Numbers Game - Tænk som en baseballtræner og find de mest attraktive aktier

24-05-2019 06:00:00
I denne episode er Maj Invests aktiechef Kura Kara og tidligere landholdsspiller og professionel basketballspiller Jens Laulund gæster i studiet til en samtale om, hvordan kvantitative analytiske metoder har vundet indpas i professionel holdsport - særligt i USA - og hvordan disse analysemetoder, der i stigende grad anvendes i  f.eks.baseball og basketball, kan lære os meget om investeringsstrateg..

Snabe køber aktier for lige under 1 mio. kr.

24-05-2019 16:07:03
Bestyrelsesformand i A.P. Møller - Mærsk Jim Hagemann Snabe har spenderet en lille million kr. på køb af aktier i firmaet.Snabe har helt præcist købt 144 stk. A-aktier i firmaet til en kurs på 6925 kr. og en samlet kursværdi af 997.200 kr.Mærsk-aktierne er fredag under pres efter selskabets regnskab for første kvartal, der blev offentliggjort fredag før børsåbningen.Mærsks A-aktie ligger kl. 16 fr..

Amerikansk hedgefund øger shortposition på Abmu til 288 mio.

24-05-2019 15:10:00
Eminence Capital har øget sin shortposition i Ambu og har nu shortet 1,21 pct. af den samlede aktiekapital i biotekselskabet mod tidligere 1,03 pct.Det fremgår fredag eftermiddag af en indberetning til Finanstilsynet. Ændringen i positionen er foretaget torsdag, fremgår det af meddelelsen.At gå kort i en aktie er at spekulere i et kursfald. Det sker ved, at spekulanten låner aktier i et selskab, s..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. maj 2019 01:10:51
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190514.2 - EUROWEB4 - 2019-05-27 01:10:51 - 2019-05-27 01:10:51 - 1 - Website: OKAY